ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 138 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q4 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $42,106 | -88.4% | 1,648 | -86.9% | 0.00% | -91.7% |
Q2 2023 | $361,855 | +269941.0% | 12,617 | +125.7% | 0.01% | +200.0% |
Q1 2023 | $134 | +737.5% | 5,591 | +496.7% | 0.00% | +300.0% |
Q4 2022 | $16 | -100.0% | 937 | -74.9% | 0.00% | 0.0% |
Q3 2022 | $55,000 | -50.9% | 3,727 | -47.7% | 0.00% | -66.7% |
Q2 2022 | $112,000 | +1144.4% | 7,130 | +2028.4% | 0.00% | – |
Q1 2022 | $9,000 | -89.5% | 335 | -85.6% | 0.00% | -100.0% |
Q4 2021 | $86,000 | -62.4% | 2,323 | -51.5% | 0.00% | -83.3% |
Q3 2021 | $229,000 | +387.2% | 4,786 | +241.9% | 0.01% | +500.0% |
Q2 2021 | $47,000 | -89.0% | 1,400 | -86.5% | 0.00% | -85.7% |
Q1 2021 | $428,000 | +17.9% | 10,357 | +23.8% | 0.01% | -36.4% |
Q4 2020 | $363,000 | +108.6% | 8,365 | +105.9% | 0.01% | +450.0% |
Q3 2020 | $174,000 | +411.8% | 4,062 | +458.7% | 0.00% | +100.0% |
Q2 2020 | $34,000 | -12.8% | 727 | -79.6% | 0.00% | -66.7% |
Q4 2019 | $39,000 | – | 3,569 | +6763.5% | 0.00% | – |
Q2 2019 | $0 | – | 52 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tri Locum Partners LP | 208,886 | $5,337,037 | 1.71% |
Portolan Capital Management | 276,505 | $7,064,703 | 0.66% |
Nikko Asset Management Americas, Inc. | 1,388,574 | $35,422,523 | 0.42% |
Green Alpha Advisors, LLC | 21,538 | $550,296 | 0.42% |
SummerHaven Investment Management, LLC | 22,326 | $570,429 | 0.42% |
ARK Investment Management | 1,901,546 | $48,584,508 | 0.37% |
Granahan Investment Management | 398,862 | $10,190,924 | 0.36% |
FEDERATED HERMES, INC. | 4,711,512 | $120,379,132 | 0.32% |
Woodline Partners LP | 1,069,814 | $27,333,748 | 0.32% |
Diametric Capital, LP | 26,130 | $667,621 | 0.28% |